Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEVEN M KATZMAN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1700992054
CMS profile
304208
Location
LIVONIA, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$119,998.36

242 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 5 of 5; records 201–242 of 242 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEVEN M KATZMAN

NPI 1700992054 · CMS profile ID 304208

Allopathic & Osteopathic Physicians / Internal Medicine

LIVONIA, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 5; records 201–242 of 242 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1700992054?year=2023&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEVEN M KATZMAN, NPI 1700992054, CMS profile ID 304208. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–242 of 242 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1700992054?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). STEVEN M KATZMAN, NPI 1700992054, CMS profile ID 304208. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–242 of 242 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1700992054?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
STEVEN M KATZMAN, NPI 1700992054, CMS profile ID 304208, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 5; records 201–242 of 242 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1700992054?year=2023&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

242 matching records · $119,998.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 242 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–242 of 242.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $104.8603/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683655 CMS
Novo Nordisk Inc $12.1003/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000437367 CMS
Amgen Inc. $1,117.2003/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683585 CMS
Amgen Inc. $74.9103/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683623 CMS
Amgen Inc. $93.0003/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683641 CMS
Amgen Inc. $33.4803/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683671 CMS
Novo Nordisk Inc $15.4703/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000437383 CMS
Amgen Inc. $2,100.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683565 CMS
Amgen Inc. $350.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683575 CMS
Amgen Inc. $102.5803/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683559 CMS
Amgen Inc. $2,100.0003/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683599 CMS
Amgen Inc. $350.0003/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683607 CMS
Amgen Inc. $1,256.8503/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683583 CMS
Amgen Inc. $1,160.7903/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683617 CMS
Amgen Inc. $87.4503/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683593 CMS
Amgen Inc. $159.8003/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683621 CMS
Amgen Inc. $424.7403/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683639 CMS
Amgen Inc. $86.0803/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683555 CMS
Amgen Inc. $2,100.0003/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683573 CMS
Amgen Inc. $350.0003/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683581 CMS
Amgen Inc. $93.0103/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683563 CMS
Amgen Inc. $2,100.0003/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683567 CMS
Amgen Inc. $350.0003/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683577 CMS
Amgen Inc. $12.7903/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020151663 CMS
Amgen Inc. $1,243.5503/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683587 CMS
Amgen Inc. $50.6503/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683561 CMS
Amgen Inc. $1,125.0003/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683589 CMS
Amgen Inc. $97.6002/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683557 CMS
Novo Nordisk Inc $9.8102/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000437351 CMS
ABBVIE INC. $19.3102/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997613919 CMS
Amgen Inc. $424.7402/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683613 CMS
Abbott Laboratories $23.7302/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018527699 CMS
Janssen Pharmaceuticals, Inc $103.0802/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987958533 CMS
Novartis Pharmaceuticals Corporation $17.1402/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992331649 CMS
IDORSIA PHARMACEUTICALS US INC $23.3402/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038230213 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.7802/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997080059 CMS
Amgen Inc. $16.6001/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020683543 CMS
Novo Nordisk Inc $21.7401/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000426147 CMS
ABBVIE INC. $29.9501/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997613917 CMS
Novo Nordisk Inc $9.8101/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000437343 CMS
ABBVIE INC. $24.9601/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997613915 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.4601/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000359405 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $109,474.68 270
PY2020 $42,046.33 129
PY2021 $108,709.63 223
PY2022 $123,804.55 237
PY2023 $119,998.36 242
PY2024 $130,525.41 191
PY2025 $80,837.88 88

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $49,569.86 11
PY2024 Principal investigator $138,083.72 19
PY2023 Principal investigator $327,066.31 51
PY2022 Principal investigator $290,132.07 56
PY2021 Principal investigator $927,593.54 66
PY2020 Principal investigator $600,756.90 44
PY2019 Recipient $991.20 2
PY2019 Principal investigator $700.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $4.90 12/31/2025 Non-covered Recipient Entity
Michigan Center of Medical Research
A Phase 2,3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults with COVID-19. No dispute reported 06/30/2026 1232927273
Principal investigator 1 Merck Sharp & Dohme LLC $20,020.56 12/31/2025 Non-covered Recipient Entity
Michigan Center of Medical Research MICHMER
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression No dispute reported 06/30/2026 1232929103
Principal investigator 1 Merck Sharp & Dohme LLC $274.40 12/31/2025 Non-covered Recipient Entity
Michigan Center of Medical Research MICHMER
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression No dispute reported 06/30/2026 1232929105
Principal investigator 1 Janssen Research & Development, LLC $3,870.00 10/03/2025 Non-covered Recipient Entity
Detroit Clinic Rsrch Ctr PC
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease (DUET-CD) No dispute reported 06/30/2026 1175233199
Principal investigator 1 Genentech, Inc. $1,500.00 06/19/2025 Non-covered Recipient Entity
MICHIGAN CENTER OF MEDICAL RESEARCH
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211625245
Principal investigator 1 Genentech, Inc. $8,500.00 06/11/2025 Non-covered Recipient Entity
MICHIGAN CENTER OF MEDICAL RESEARCH
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211625236
Principal investigator 1 Genentech, Inc. $1,500.00 06/11/2025 Non-covered Recipient Entity
MICHIGAN CENTER OF MEDICAL RESEARCH
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211625241
Principal investigator 1 PFIZER INC. $2,400.00 05/28/2025 Non-covered Recipient Entity
Michigan Center of Medical Research
AN INTERVENTIONAL PHASE 23 ADAPTIVE MULTICENTER RANDOMIZED DOUBLEBLIND STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ORAL SISUNATOVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULTS WITH RESPIRATORY SYNCYTIAL VIRUS INFECTION WHO ARE AT RISK OF PROGRESSION TO SEVERE ILLNESS No dispute reported 06/30/2026 1228764358
Principal investigator 1 Genentech, Inc. $8,500.00 03/06/2025 Non-covered Recipient Entity
MICHIGAN CENTER OF MEDICAL RESEARCH
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211625211
Principal investigator 1 Genentech, Inc. $1,500.00 03/06/2025 Non-covered Recipient Entity
MICHIGAN CENTER OF MEDICAL RESEARCH
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211625216
Principal investigator 1 Genentech, Inc. $1,500.00 03/06/2025 Non-covered Recipient Entity
MICHIGAN CENTER OF MEDICAL RESEARCH
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211625251